EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.

MLA

Zhang, Xin A., et al. “EWI2/PGRL Associates with the Metastasis Suppressor KAI1/CD82 and Inhibits the Migration of Prostate Cancer Cells.” Cancer Research, vol. 63, no. 10, May 2003, pp. 2665–74. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12750295&authtype=sso&custid=ns315887.

APA

Zhang, X. A., Lane, W. S., Charrin, S., Rubinstein, E., & Liu, L. (2003). EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. Cancer Research, 63(10), 2665–2674.

Chicago

Zhang, Xin A, William S Lane, Stephanie Charrin, Eric Rubinstein, and Lei Liu. 2003. “EWI2/PGRL Associates with the Metastasis Suppressor KAI1/CD82 and Inhibits the Migration of Prostate Cancer Cells.” Cancer Research 63 (10): 2665–74. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12750295&authtype=sso&custid=ns315887.